Events

Pre eclampsia Education

A baby and three women

Take me to:

Roche Diagnostic pre-eclampsia symposium  |  Case Study   |  Resources  | Learn from the experts

Pre-eclampsia

Pre-eclampsia is a serious multi-system complication of pregnancy, occurring in 3-5% of pregnancies, and it is one of the leading causes of maternal and perinatal morbidity and mortality worldwide.1-3 The landmark multicentre, prospective study – PROGNOSIS (Prediction of short-term outcome in pregnant women with suspected pre-eclampsia study) – demonstrated that the Elecsys® sFlt-1/PlGF ratio test can aid in the short term prediction of pre-eclampsia and, together with other clinical information, enables clinicians to rule out pre-eclampsia with high confidence for at least 1 week.4-5

 

Video recording

Symposium:

Recent advances in the assessment of pre-eclampsia

On 11th March 2021 Roche Diagnostics hosted a symposium on the adoption of Elecsys® sFlt-1/PIGF ratio test in clinical practice. The objective was to engage with clinicians and laboratory healthcare professionals in the pre-eclampsia and pregnancy care community, with talks on the following topics:

 

  • Implementation of PIGF-based testing: experience from the Great Manchester region - Jenny Myers
  • Implementation of pre-eclampsia markers: insights into assay performance and clinical models - Shonagh Haslam
  • Implementation of pre-eclampsia markers, insight into the laboratory practicalities - Amy Kiley

 

 

Symposium Speaker Biographies

Video recording

Implementation into clinical practice of the Elecsys® sFlt-1/PIGF ratio test: a case study from the John Radcliffe Hospital

The John Radcliffe Hospital is a tertiary referral centre that serves the Thames Valley region and South Midlands. It provides tertiary referral centre services for maternity, obstetrics and neonatology; patients who are unwell and preterm are transferred to the centre. A significant number of patients with either pre-eclampsia or suspected pre-eclampsia attend the unit. Clinical signs and symptoms often lack accuracy to diagnose pre-eclampsia and this prompted a rationale for assessing the use of sFlt-1/PIGF ratio in a clinical trial setting. Click here to read the full case study.

 

 

Case study: Download the article

Resources

Learn more about the assessment and management of pre-eclampsia by taking our educational module and gaining continuing professional development (CPD) points. Additionally, you can find the NICE guidances on pre-eclampsia (DG23) and hypertension in pregnancy (NG133). 

 

Assessment of pre-eclampsia: learn from the experts

In this section you will find presentations from:

  • Recent advances in the assessment of pre-eclampsia recorded on 11th March 2021
  • Dr Sofia Cerdeira on the change in clinical practice in the assessment of pre-eclampsia at the John Radcliffe Hospital
  • Toni Brunt on PIGF - based testing at Doncaster & Bassetlaw Teaching Hospitals for the assessment of pre-eclampsia

 

 

Learn from the experts

Additional case studies and news on the adoption of the Elecsys® sFlt-1/PIGF ratio test for the assessment of pre-eclampsia.

 

References

  1. Verlohren, S., et al. (2012). Am J Obstet Gynecol 206(1), e1-8
  2. Verlohren, S., et al. (2010). Am J Obstet Gynecol 202(161), e1-11
  3. Verlohren, S., et al. (2014). Hypertension 63(2), 346-352
  4. Hund, M., et al. (2014). BMC Pregnancy and Childbirth 14, 324
  5. Zeisler, H., et al. (2016). N Engl J Med 374(1), 13-22